Shine Investment Advisory Services’s Moderna MRNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q3
$17K Hold
238
0.01% 471
2020
Q2
$15K Buy
+238
New +$13K 0.01% 496
2020
Q1
Sell
-316
Closed -$6K 755
2019
Q4
$6K Sell
316
-283
-47% -$5.02K ﹤0.01% 648
2019
Q3
$10K Hold
599
﹤0.01% 555
2019
Q2
$9K Buy
599
+220
+58% +$4.72K ﹤0.01% 555
2019
Q1
$8K Hold
379
﹤0.01% 576
2018
Q4
$6K Buy
+379
New +$6.23K ﹤0.01% 596

Other funds holding MRNA

Shine Investment Advisory Services's MRNA Position: Q3 2020 in Review

Shine Investment Advisory Services held its Moderna (MRNA) position steady in Q3 2020 at 238 shares worth $17K. The position accounts for 0.01% of the portfolio, ranked #471.

Shine Investment Advisory Services first reported a position in MRNA in Q4 2018 and has held it in 7 quarters since. 548 funds tracked by Wall St. Rank hold MRNA as of Q3 2020.

  • Shine Investment Advisory Services held 238 shares of Moderna worth $17K as of Q3 2020.
  • Shine Investment Advisory Services left its Moderna share count unchanged in Q3 2020.
  • Moderna made up 0.01% of Shine Investment Advisory Services's portfolio in Q3 2020, its #471 holding.
  • Shine Investment Advisory Services first reported a position in Moderna in Q4 2018 and has held it in 7 quarters since.
  • 548 funds tracked by Wall St. Rank held Moderna as of Q3 2020.

Based on Shine Investment Advisory Services's 13F filing for Q3 2020, filed 3 Nov 2020.